Koers Shandong Jincheng Pharmaceutical Group Co., Ltd
Aandelen
300233
CNE100001500
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,56 CNY | -2,26% | -7,98% | -6,60% |
Omzet 2021 | 3,14 mld. 434 mln. 402 mln. | Omzet 2022 | 3,51 mld. 485 mln. 449 mln. | Marktkapitalisatie | 8,74 mld. 1,21 mld. 1,12 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 108 mln. 14,94 mln. 13,84 mln. | Nettowinst (verlies) 2022 | 273 mln. 37,78 mln. 34,98 mln. | EV/omzet 2021 | 3,45 x |
Nettoliquiditeiten 2021 | 329 mln. 45,46 mln. 42,09 mln. | Nettoliquiditeiten 2022 | 208 mln. 28,81 mln. 26,68 mln. | EV/omzet 2022 | 2,43 x |
K/w-verhouding 2021 |
104
x | K/w-verhouding 2022 |
32,1
x | Werknemers | 3.963 |
Dividendrendement 2021 |
0,68% | Dividendrendement 2022 |
0,66% | Vrij verhandelbaar | 29,55% |
1 dag | -2,26% | ||
1 week | -7,98% | ||
Lopende maand | +7,24% | ||
1 maand | +6,79% | ||
3 maanden | -3,35% | ||
6 maanden | -18,83% | ||
Lopend jaar | -6,60% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jia Quan Li
PSD | President | 52 | 01-02-08 |
Jing Liu
DFI | Director of Finance/CFO | 48 | - |
Geng Xiu Zheng
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ye Qing Zhao
CHM | Chairman | 47 | 01-07-04 |
Geng Xiu Zheng
CTO | Chief Tech/Sci/R&D Officer | 60 | 01-01-04 |
Xi Li Cui
BRD | Director/Board Member | 51 | 16-02-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 36 M€ | +4,88% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 15,84 | +1,80% | 3 325 137 |
27-03-24 | 15,56 | -2,26% | 4 898 747 |
26-03-24 | 15,92 | -0,38% | 2 600 271 |
25-03-24 | 15,98 | -2,26% | 3 076 513 |
22-03-24 | 16,35 | -2,45% | 5 259 605 |
slotkoers Shenzhen S.E., 27 maart 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,60% | 819 mln. | |
+14,56% | 9,82 mld. | |
-7,87% | 5,49 mld. | |
+12,50% | 4,21 mld. | |
+16,55% | 3,66 mld. | |
+44,73% | 2,93 mld. | |
-19,01% | 2,54 mld. | |
-21,20% | 2,35 mld. | |
+16,10% | 1,85 mld. | |
-0,50% | 1,64 mld. |